HKSE:03320'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.78 Med: 9.19 Max: 13.98
Current: 10.32
During the past 11 years, China Resources Pharmaceutical Group's highest Shiller PE Ratio was 13.98. The lowest was 7.78. And the median was 9.19.
HKSE:03320's Shiller PE Ratio is ranked better than 87.99% of 533
companies
in the Drug Manufacturers industry
Industry Median: 25.16
vs HKSE:03320: 10.32
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
China Resources Pharmaceutical Group's adjusted earnings per share data of for the fiscal year that ended in Dec23 was HK$0.667. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.60 for the trailing ten years ended in Dec23.
Shiller PE for Stocks: The True Measure of Stock Valuation
China Resources Pharmaceutical Group Shiller PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Resources Pharmaceutical Group Shiller PE Ratio Chart
Competitive Comparison of China Resources Pharmaceutical Group's Shiller PE Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Pharmaceutical Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where China Resources Pharmaceutical Group's Shiller PE Ratio falls into.
China Resources Pharmaceutical Group Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
China Resources Pharmaceutical Group (HKSE:03320) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
China Resources Pharmaceutical Group Shiller PE Ratio Related Terms
Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
China Resources Pharmaceutical Group (HKSE:03320) Business Description
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. We estimate the company's operating income is approximately 53% distribution, 46% manufacturing, and less than 1% retail pharmacies.
China Resources Pharmaceutical Group (HKSE:03320) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:03320 has been successfully added to your 